metaPreg - Loflazepate during pregnancy

Loflazepate updated on 02-10-2025

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
Congenital heart defects	2.43 [1.33, 4.43]	-	1 study	83,594	132	not evaluable	ROB	4.29 [2.00; .]
2 non statistically significant endpoints reported in only one study